gentian violet has been researched along with Hormone-Dependent Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carty, MP; Claffey, J; Cuffe, S; Dowling, CM; Fitzpatrick, JM; Hogan, M; Pampillón, C; Tacke, M; Watson, RW | 1 |
| Bernhardt, G; Birnböck, H; Reile, H; Schönenberger, H; Spruss, T | 1 |
2 other study(ies) available for gentian violet and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Comet Assay; DNA Damage; Gentian Violet; Humans; Male; Neoplasms, Hormone-Dependent; Organometallic Compounds; Prostatic Neoplasms; Titanium | 2011 |
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cell Division; Cisplatin; Diethylstilbestrol; Drug Screening Assays, Antitumor; Female; Fluorouracil; Gentian Violet; Humans; Kinetics; Melphalan; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Vinblastine | 1992 |